跳至主要内容
临床试验/DRKS00017396
DRKS00017396已完成不适用

MA Gastro™ Airway is feasible during upper gastrointestinal interventional endoscopic procedures in high risk patients: a single-center retrospective analysis

Klinik für Anästhesiologie und IntensivmedizinUNIVERSITÄTSKLINIKUM FREIBURG0 个研究点目标入组 31 人开始时间: 2019年5月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
31

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
10 Years 至 one(—)
性别
All

入选标准

  • Inclusion criteria were high-risk patients undergoing elective upper gastrointestinal endoscopic procedures and interventions with the need of general anesthesia. Airway management with LMA GastroTM, ASA status 3 or above, age 10 years and older, body weight above 30 kg. Patients fasted at least for 6 hours regarding solids and at least two hours for fluids other than water. It was our intention not to exclude any patients with oesophageal reflux, oesophageal strictures, cancer of the upper gastrointestinal tract or the stomach, achalasia, pancreatitis, upper GI bleeding, colitis, pyloric stenosis, morbid obesity etc.

排除标准

  • Patients below the age of 10 years

研究者

发起方
Klinik für Anästhesiologie und IntensivmedizinUNIVERSITÄTSKLINIKUM FREIBURG

相似试验

MA Gastro™ Airway is feasible during upper... | 临床试验